AAAAAA

   
Results: 1-15 |
Results: 15
Induction of topoisomerase II activity after ErbB2 activation is associated with a differential response to breast cancer chemotherapy
Authors: Harris, LN Yang, L Liotcheva, V Pauli, S Iglehart, JD Colvin, OM Hsieh, TS
Citation: Ln. Harris et al., Induction of topoisomerase II activity after ErbB2 activation is associated with a differential response to breast cancer chemotherapy, CLIN CANC R, 7(6), 2001, pp. 1497-1504
Intraneoplastic polymer-based delivery of cyclophosphamide for intratumoral bioconversion by a replicating oncolytic viral vector
Authors: Ichikawa, T Petros, WP Ludeman, SM Fangmeier, J Hochberg, FH Colvin, OM Chiocca, EA
Citation: T. Ichikawa et al., Intraneoplastic polymer-based delivery of cyclophosphamide for intratumoral bioconversion by a replicating oncolytic viral vector, CANCER RES, 61(3), 2001, pp. 864-868
Phase I trial of carmustine plus O-6-benzylguanine for patients with recurrent or progressive malignant glioma
Authors: Friedman, HS Pluda, J Quinn, JA Ewesuedo, RB Long, L Friedman, AH Cokgor, I Colvin, OM Haglund, MM Ashley, DM Rich, JN Sampson, J Pegg, AE Moschel, RC McLendon, RE Provenzale, JM Stewart, ES Tourt-Uhlig, S Garcia-Turner, AM Herndon, JE Bigner, DD Dolan, ME
Citation: Hs. Friedman et al., Phase I trial of carmustine plus O-6-benzylguanine for patients with recurrent or progressive malignant glioma, J CL ONCOL, 18(20), 2000, pp. 3522-3528
Camptothecin analogues with enhanced antitumor activity at acidic pH
Authors: Adams, DJ Dewhirst, MW Flowers, JL Gamcsik, MP Colvin, OM Manikumar, G Wani, MC Wall, ME
Citation: Dj. Adams et al., Camptothecin analogues with enhanced antitumor activity at acidic pH, CANC CHEMOT, 46(4), 2000, pp. 263-271
Evidence for a role of chloroethylaziridine in the cytotoxicity of cyclophosphamide
Authors: Flowers, JL Ludeman, SM Gamcsik, MP Colvin, OM Shao, KL Boal, JH Springer, JB Adams, DJ
Citation: Jl. Flowers et al., Evidence for a role of chloroethylaziridine in the cytotoxicity of cyclophosphamide, CANC CHEMOT, 45(4), 2000, pp. 335-344
Efficacy of liposomes and hyperthermia in a human tumor xenograft model: Importance of triggered drug release
Authors: Kong, G Anyarambhatla, G Petros, WP Braun, RD Colvin, OM Needham, D Dewhirst, MW
Citation: G. Kong et al., Efficacy of liposomes and hyperthermia in a human tumor xenograft model: Importance of triggered drug release, CANCER RES, 60(24), 2000, pp. 6950-6957
An overview of cyclophosphamide development and clinical applications
Authors: Colvin, OM
Citation: Om. Colvin, An overview of cyclophosphamide development and clinical applications, CUR PHARM D, 5(8), 1999, pp. 555-560
Metabolic jeopardy with high-dose cyclophosphamide? Not so fast
Authors: Petros, WP Colvin, OM
Citation: Wp. Petros et Om. Colvin, Metabolic jeopardy with high-dose cyclophosphamide? Not so fast, CLIN CANC R, 5(4), 1999, pp. 723-724
Irinotecan therapy in adults with recurrent or progressive malignant glioma
Authors: Friedman, HS Petros, WP Friedman, AH Schaaf, LJ Kerby, T Lawyer, J Parry, M Houghton, PJ Lovell, S Rasheed, K Cloughsey, T Stewart, ES Colvin, OM Provenzale, JM McLendon, RE Bigner, DD Cokgor, I Haglund, M Rich, J Ashley, D Malczyn, J Elfring, GL Miller, LL
Citation: Hs. Friedman et al., Irinotecan therapy in adults with recurrent or progressive malignant glioma, J CL ONCOL, 17(5), 1999, pp. 1516-1525
Multiple DNA repair mechanisms and alkylator resistance in the human medulloblastoma cell line D-283 Med (4-HCR)
Authors: Dong, Q Johnson, SP Colvin, OM Bullock, N Kilborn, C Runyon, G Sullivan, DM Easton, J Bigner, DD Nahta, R Marks, J Modrich, P Friedman, HS
Citation: Q. Dong et al., Multiple DNA repair mechanisms and alkylator resistance in the human medulloblastoma cell line D-283 Med (4-HCR), CANC CHEMOT, 43(1), 1999, pp. 73-79
Modulation of cyclophosphamide activity by O-6-alkylguanine-DNA alkyltransferase
Authors: Friedman, HS Pegg, AE Johnson, SP Loktionova, NA Dolan, ME Modrich, P Moschel, RC Struck, R Brent, TP Ludeman, S Bullock, N Kilborn, C Keir, S Dong, Q Bigner, DD Colvin, OM
Citation: Hs. Friedman et al., Modulation of cyclophosphamide activity by O-6-alkylguanine-DNA alkyltransferase, CANC CHEMOT, 43(1), 1999, pp. 80-85
Intrathecal busulfan treatment of human neoplastic meningitis in athymic nude rats
Authors: Archer, GE Sampson, JH McLendon, RE Friedman, AH Colvin, OM Rose, M Sands, H McCullough, W Fuchs, HE Bigner, DD Friedman, HS
Citation: Ge. Archer et al., Intrathecal busulfan treatment of human neoplastic meningitis in athymic nude rats, J NEURO-ONC, 44(3), 1999, pp. 233-241
Pre-clinical evaluation of SN-38 and novel camptothecin analogs against human chronic B-cell lymphocytic leukemia lymphocytes
Authors: Cohen, DP Adams, DJ Flowers, JL Wall, ME Wani, MC Manikumar, G Colvin, OM Silber, R
Citation: Dp. Cohen et al., Pre-clinical evaluation of SN-38 and novel camptothecin analogs against human chronic B-cell lymphocytic leukemia lymphocytes, LEUK RES, 23(11), 1999, pp. 1061-1070
Isolation of primitive human hematopoietic progenitors on the basis of aldehyde dehydrogenase activity
Authors: Storms, RW Trujillo, AP Springer, JB Shah, L Colvin, OM Ludeman, SM Smith, C
Citation: Rw. Storms et al., Isolation of primitive human hematopoietic progenitors on the basis of aldehyde dehydrogenase activity, P NAS US, 96(16), 1999, pp. 9118-9123
DNA mismatch repair and O-6-alkylguanine-DNA alkyltransferase analysis andresponse to temodal in newly diagnosed malignant glioma
Authors: Friedman, HS McLendon, RE Kerby, T Dugan, M Bigner, SH Henry, AJ Ashley, DM Krischer, J Lovell, S Rasheed, K Marchev, F Seman, AJ Cokgor, I Rich, J Stewart, E Colvin, OM Provenzale, JM Bigner, DD Haglund, MM Friedman, AH Modrich, PL
Citation: Hs. Friedman et al., DNA mismatch repair and O-6-alkylguanine-DNA alkyltransferase analysis andresponse to temodal in newly diagnosed malignant glioma, J CL ONCOL, 16(12), 1998, pp. 3851-3857
Risultati: 1-15 |